FDAnews Device Daily Bulletin

NEW TEST PREDICTS RETURN OF CANCER

May 1, 2006
A A

A new test that combines multiple scientific disciplines can predict accurately which men are either at high or low risk for a return of cancer after surgical removal of the prostate gland. The test, known as Prostate PX, is the first and only diagnostic test that combines cellular, molecular and clinical information about a patient with advanced computer technology and digital imaging to deliver the patient's individual risk for a recurrence of cancer.
The Washington Times